Filters close
Newswise: RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial
Released: 29-May-2024 5:30 AM EDT
RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial
Mount Sinai Health System

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

Newswise: Two New Studies by Mount Sinai Researchers in Science Offer Key Insights Into the Origins and Potential Treatment of Mental Health Disorders
22-May-2024 5:05 PM EDT
Two New Studies by Mount Sinai Researchers in Science Offer Key Insights Into the Origins and Potential Treatment of Mental Health Disorders
Mount Sinai Health System

Working under the umbrella of the PsychENCODE Consortium, the mental health research project established in 2015 by the National Institutes of Health, a team of Mount Sinai scientists has uncovered important new insights into the molecular biology of neuropsychiatric disease through two new studies published in a special issue of Science on Friday, May 24.

Newswise: Valentin Fuster, MD, PhD, Receives Prestigious Award From World Heart Federation
Released: 23-May-2024 9:30 AM EDT
Valentin Fuster, MD, PhD, Receives Prestigious Award From World Heart Federation
Mount Sinai Health System

President of Mount Sinai Fuster Heart Hospital given top honor for his contributions to combating cardiovascular disease worldwide

Newswise: Mount Sinai's The Louis Armstrong Center for Music and Medicine Celebrates 30th Anniversary With a Commemorative Conference
Released: 23-May-2024 8:05 AM EDT
Mount Sinai's The Louis Armstrong Center for Music and Medicine Celebrates 30th Anniversary With a Commemorative Conference
Mount Sinai Health System

The Louis Armstrong Center for Music and Medicine at Mount Sinai is celebrating its 30th anniversary.

16-May-2024 3:00 PM EDT
AI Can Help Improve ER Admission Decisions, Mount Sinai Study Finds
Mount Sinai Health System

Generative artificial intelligence (AI), such as GPT-4, can help predict whether an emergency room patient needs to be admitted to the hospital even with only minimal training on a limited number of records, according to investigators at the Icahn School of Medicine at Mount Sinai.

Newswise: Nano Drug Accelerates Diabetic Wound Healing in Mice
16-May-2024 3:05 PM EDT
Nano Drug Accelerates Diabetic Wound Healing in Mice
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have designed a regenerative medicine therapy to speed up diabetic wound repair. Using tiny fat particles loaded with genetic instructions to calm down inflammation, the treatment was shown to target problem-causing cells and reduce swelling and harmful molecules in mouse models of damaged skin. Details on their findings were published in the May 20 online issue of the Proceedings of the National Academy of Sciences (PNAS).

Released: 16-May-2024 10:30 AM EDT
Mount Sinai Awarded $6.6 Million From National Institutes of Health to Investigate Treatment for Alopecia Areata in Children
Mount Sinai Health System

The Icahn School of Medicine at Mount Sinai Health System is spearheading a collaborative effort to investigate dupilumab as a treatment for children with alopecia areata, a disease that causes extensive hair loss.

Newswise: Mount Sinai’s Yvette Calderon, MD, MS, Receives Prestigious Award From Society for Academic Emergency Medicine
Released: 16-May-2024 7:30 AM EDT
Mount Sinai’s Yvette Calderon, MD, MS, Receives Prestigious Award From Society for Academic Emergency Medicine
Mount Sinai Health System

Top honor recognizes her commitment to justice, equity, diversity, and inclusion through scholarship, mentorship, and leadership

Newswise: Mount Sinai Study Identifies Genetic Link Between Inflammatory Bowel Disease and Parkinson’s Disease
13-May-2024 12:05 PM EDT
Mount Sinai Study Identifies Genetic Link Between Inflammatory Bowel Disease and Parkinson’s Disease
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery, identifying genetic connections between inflammatory bowel disease (IBD) and Parkinson’s disease (PD). Published in Genome Medicine on May 13, their study highlights the potential for joint therapeutic strategies to target these two challenging disorders.

Newswise: Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits
7-May-2024 3:05 PM EDT
Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatric disorders such as depression and anxiety.

Released: 1-May-2024 12:05 PM EDT
Mount Sinai Celebrates 20th Anniversary of East Harlem Health Outreach Partnership and a Legacy of Community Service
Mount Sinai Health System

Twenty years ago today, the East Harlem Health Outreach Partnership (EHHOP) at Mount Sinai opened its doors, creating a new model of community service and patient care. EHHOP, a free student-run, physician-supervised clinic, serves approximately 300 residents of East Harlem every year.

Newswise:Video Embedded icahn-school-of-medicine-at-mount-sinai-names-miriam-merad-md-phd-as-dean-for-translational-research-and-therapeutic-innovation
VIDEO
29-Apr-2024 9:00 AM EDT
Icahn School of Medicine at Mount Sinai Names Miriam Merad, MD, PhD, as Dean for Translational Research and Therapeutic Innovation
Mount Sinai Health System

Miriam Merad, MD, PhD, a world-renowned immunologist, has been appointed Dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai. The appointment reaffirms Icahn Mount Sinai’s commitment to pioneering medical progress and catalyzing the rapid advancement of research innovation. Dr. Merad, the Mount Sinai Professor in Cancer Immunology, will also continue to serve as the founding Chair of the Department of Immunology and Immunotherapy, Director of the Marc and Jennifer Lipschultz Precision Immunology Institute, and Director of the Human Immune Monitoring Center. As Dean, Dr. Merad aims to elevate early clinical trials at Icahn Mount Sinai, streamline the clinical trial process, cultivate a culture of mechanistic clinical trials throughout the campus, and forge stronger partnerships with the pharmaceutical and biotech sectors.

Newswise: Mount Sinai Researchers the First to Apply Single-Cell Analysis to Reveal Mechanisms of a Common Complication of Crohn’s Disease
22-Apr-2024 1:00 PM EDT
Mount Sinai Researchers the First to Apply Single-Cell Analysis to Reveal Mechanisms of a Common Complication of Crohn’s Disease
Mount Sinai Health System

Study identifies key pathways underlying perianal fistula, a disease complication that is more prevalent and severe in African Ameri can populations

Released: 22-Apr-2024 3:00 PM EDT
Mount Sinai Scientists Discover the Cellular Functions of a Family of Proteins Integral to Inflammatory Diseases
Mount Sinai Health System

In a scientific breakthrough, Mount Sinai researchers have revealed the biological mechanisms by which a family of proteins known as histone deacetylases (HDACs) activate immune system cells linked to inflammatory bowel disease (IBD) and other inflammatory diseases.

Released: 22-Apr-2024 9:00 AM EDT
Despite AI Advancements, Human Oversight Remains Essential
Mount Sinai Health System

State-of-the-art artificial intelligence systems known as large language models (LLMs) are poor medical coders, according to researchers at the Icahn School of Medicine at Mount Sinai.



close
0.1587